U.S. PRP And Stem Cell Alopecia Treatment Market To Reach $438.91 Million By 2030

U.S. PRP And Stem Cell Alopecia Treatment Market Growth & Trends

The U.S. PRP and stem cell alopecia treatment market size is anticipated to reach USD 438.91 million by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 9.46% from 2025 to 2030. Factors contributing to the growth of this market include rise in disease awareness, increased treatment rate, and growing adoption of novel treatment therapies providing a positive patient outcome. Moreover, lower incidence of negative side effects due to this therapy is anticipated to fuel demand for platelet-rich plasma (PRP) and stem cell therapy.

Adoption of PRP and stem cell therapy for alopecia is expected to increase owing to a rise in the number of patients preferring novel therapies over conventional therapies. In addition to this, shorter treatment duration, faster hair regrowth, and improved patient outcome are expected to drive demand for these therapies over the forecast period.

By treatment type, PRP procedures accounted for the largest share of 58.1% in 2017 in terms of procedural volume. However, owing to lower prices of PRP procedures, stem cell therapy procedures accounted for the dominant revenue share in 2017, valued at USD 70.1 million. By end use, the dermatology clinics segment accounted for 85.0% of the total market revenue in 2017, owing to its lower therapy cost as compared to hospitals.

The competitive landscape includes clinics such as Orange County Hair Restoration Center, Hair Sciences Center of Colorado, Evolution Hair Loss Institute, Savola Aesthetic Dermatology Center, PLC, NovaGenix, Virginia Surgical Center, and Hair Transplant Institute of Miami.

 Request a free sample copy or view report summary: U.S. PRP And Stem Cell Alopecia Treatment Market Report

U.S. PRP And Stem Cell Alopecia Treatment Market Report Highlights

• Stem cell therapy is expected to grow significantly at a CAGR of 12.47% over the forecast period, owing to its promising applications in treating various conditions, including hair loss and degenerative diseases.

• Androgenic alopecia dominated the market and accounted for the largest revenue share of 71.51% in 2024 attributed to its high prevalence, affecting approximately 50 million men and 30 million women.

• Dermatology clinics dominated the market and accounted for the largest revenue share of 69.60% in 2024 driven by the rising prevalence of skin conditions and hair loss disorders, such as androgenic alopecia.

U.S. PRP And Stem Cell Alopecia Treatment Market Segmentation

Grand View Research has segmented the global U.S. PRP and stem cell alopecia treatment market report based on treatment, indication, and end-use.

U.S. PRP And Stem Cell Alopecia Treatment Treatment Outlook (Revenue, USD Million, 2018 - 2030)

• Platelet Rich Plasma Therapy

• Stem Cell Therapy

U.S. PRP And Stem Cell Alopecia Treatment Indication Outlook (Revenue, USD Million, 2018 - 2030)

• Androgenic Alopecia

• Alopecia Areata

• Cicatricial Alopecia

• Other Indications

U.S. PRP And Stem Cell Alopecia Treatment End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Dermatology Clinics

• Others

List Of Key Players in the U.S. PRP And Stem Cell Alopecia Treatment Market

• Bauman Medical Group, P.A.

• Virginia Surgical Center

• Nova Medical Hair Transplant

• Chicago Hair Transplant Clinic

• Dr. V Medical Aesthetics

• City Facial Plastics

• Orange County Hair Restoration

• MAXIM Hair Restoration

• New Jersey Hair Restoration Center

• Hair Restoration Institute of Minnesota

• Morgenstern Hair Restoration LLC.

• Houston Hair Transplant Center